CLINICAL_TRIALS
withdrawal
· 2022-02-18
Clinical Trial Update: A Study of Etoricoxib in Participants With Osteoarthritis Not Responding to Analgesic Drugs (MK-0663-142) [Phase 4]
Summary
A Phase 4 clinical trial of etoricoxib in osteoarthritis participants not responding to analgesics was withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Organon and Co | Conditions: Osteoarthritis | Phase 4 | Status: WITHDRAWN